Philippine Orthopedic Center

The Institute for Orthopaedic Surgery & Sports Medicine Joins HOPCo in Partnership with Orthopedic Center of Florida

Retrieved on: 
Thursday, September 14, 2023

FORT MYERS, Fla., Sept. 14, 2023 /PRNewswire/ -- The Institute for Orthopaedic Surgery & Sports Medicine (IOSSM) has announced they have become part of HOPCo's Florida-based musculoskeletal practice management platform and will partner with Orthopedic Center of Florida to become one of the largest integrated provider groups in the region.   Orthopedic Center of Florida partnered with HOPCo in late 2022 and has already seen significant growth with the addition of 5 providers and the opening of an additional office location in Naples, FL.

Key Points: 
  • Healthcare Outcomes Performance Company (HOPCo) is the national leader in musculoskeletal practice and clinical outcomes management solutions and the country's largest orthopedic value-based care organization.
  • Combined, IOSSM and Orthopedic Center of Florida will have 4 locations and 28 musculoskeletal providers.
  • "The physicians at IOSSM have an outstanding reputation for patient care," said Dr. John Mehalik of Orthopedic Center of Florida.
  • IOSSM is the newest addition to HOPCo's growing national musculoskeletal market transformation platform and the ninth HOPCo partnership in Florida.

Mercy Medical Center Nurses to Hold Informational Picket in Springfield on July 17 to Protest Trinity Health's Closure of Intermediate Care Beds and Other Broken Promises Impacting Patients and Staff

Retrieved on: 
Thursday, July 13, 2023

SPRINGFIELD, Mass., July 13, 2023 /PRNewswire/ -- Registered nurses at Mercy Medical Center, represented by the Massachusetts Nurses Association, will hold an informational picket outside the hospital on July 17 in response to corporate owner Trinity Health recently closing 20 intermediate care beds, "temporarily" closing other essential services without any indication they will be re-opened, and creating a staffing and patient care crisis.

Key Points: 
  • When: Monday, July 17 from 12 p.m. to 1 p.m.
    Where: On the sidewalk outside Mercy Medical Center on Carew Street in Springfield.
  • Who: Nurses, colleagues, and community supporters will picket and talk to the public about how Trinity's detached corporate management is jeopardizing patient care quality and access.
  • "Mercy Medical Center nurses and the community are standing up to Trinity Health's broken promises on behalf of our patients," said Dee Doyle, RN, Co-Chair of the Mercy Medical Center MNA Bargaining Committee.
  • Trinity recently "temporarily" closed 20 of its intermediate care beds without notice to nurses or our union, the Massachusetts Nurses Association.

Joe DiMaggio Children's Hospital Ranked Among the Top 50 by U.S. News & World Report

Retrieved on: 
Wednesday, June 21, 2023

HOLLYWOOD, Fla., June 21, 2023 /PRNewswire-PRWeb/ -- Joe DiMaggio Children's Hospital has once again achieved national recognition for its excellence in orthopedics, earning a coveted spot among the top 50 children's hospitals in the country. This prestigious accolade comes from U.S. News & World Report, the esteemed authority in hospital rankings and consumer advice. For nine consecutive years, Joe DiMaggio Children's Hospital's Orthopedic Center has consistently received this national recognition.

Key Points: 
  • This prestigious accolade comes from U.S. News & World Report, the esteemed authority in hospital rankings and consumer advice.
  • HOLLYWOOD, Fla., June 21, 2023 /PRNewswire-PRWeb/ -- Joe DiMaggio Children's Hospital has once again achieved national recognition for its excellence in orthopedics, earning a coveted spot among the top 50 children's hospitals in the country.
  • This prestigious accolade comes from U.S. News & World Report, the esteemed authority in hospital rankings and consumer advice.
  • Joe DiMaggio Children's Hospital Orthopedic Center has several office locations throughout Broward and Palm Beach counties.

Hillcrest Hospital South Meets DNV Advanced Standards for Orthopedic Excellence

Retrieved on: 
Tuesday, February 14, 2023

Tulsa, OK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Hillcrest Hospital South has achieved designation as an Orthopedic Center of Excellence by DNV.

Key Points: 
  • Tulsa, OK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Hillcrest Hospital South has achieved designation as an Orthopedic Center of Excellence by DNV.
  • Achieving Orthopedic Center of Excellence designation requires that a hospital obtain advanced certification with DNV in at least three (3) of their orthopedic service line programs.
  • Hillcrest Hospital South has achieved advanced certification of their Hip & Knee Replacement, Spine Surgery, and Shoulder Surgery Programs.
  • Bennett Geister, CEO of Hillcrest Hospital South, stated, “Over the past five years, Orthopedic surgery has been one of the highest growth service lines at Hillcrest South.

Celebrating Major Milestones in Personalized Orthopaedics, restor3d Announces First Surgery Using the Next Generation Kinos Axiom® Total Ankle System Featuring TIDAL Technology™ and Launches Mobile Companion App of r3id Personalized Surgery Platform

Retrieved on: 
Monday, January 23, 2023

The first being the successful implantation of the next generation Kinos Axiom® Total Ankle System featuring TIDAL Technology™, and the second is today’s launch of the mobile companion App for the r3id Personalized Surgery platform.

Key Points: 
  • The first being the successful implantation of the next generation Kinos Axiom® Total Ankle System featuring TIDAL Technology™, and the second is today’s launch of the mobile companion App for the r3id Personalized Surgery platform.
  • (Graphic: Business Wire)
    The Kinos Axiom® Total Ankle System, a revolutionary innovation in total ankle arthroplasty, now features TIDAL Technology™.
  • By bringing the r3id App to iOS and Android mobile devices, users can now collaborate, design, and approve on the go.
  • “The release of the Kinos Axiom® Total Ankle System with TIDAL Technology™ is predicated on years of scientific research and engineering development.

DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease

Retrieved on: 
Monday, January 23, 2023

SALT LAKE CITY, Jan. 23, 2023 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced positive two-year clinical data from its first-in-human clinical study of IDCT (rebonuputemcel), an allogeneic discogenic progenitor cell therapy for lumbar degenerative disc disease (DDD).

Key Points: 
  • SALT LAKE CITY, Jan. 23, 2023 /PRNewswire/ -- DiscGenics, Inc. , a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced positive two-year clinical data from its first-in-human clinical study of IDCT (rebonuputemcel), an allogeneic discogenic progenitor cell therapy for lumbar degenerative disc disease (DDD).
  • In the low dose IDCT group (3,000,000 cell/mL; n=20), there was a trend in improvement of clinical outcomes, though inconsistent.
  • The 60-subject study was designed to evaluate the safety and preliminary efficacy of IDCT for the treatment of symptomatic lumbar degenerative disc disease versus vehicle and saline controls.
  • DiscGenics has submitted a full clinical study report to the U.S. Food & Drug Administration's (FDA) Office of Tissues and Advanced Therapies (OTAT).

Emanate Health First in California to Earn DNV Orthopedic Center of Excellence Designation

Retrieved on: 
Tuesday, January 17, 2023

West Covina, California, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Emanate Health has become the first hospital in California to earn the Orthopedic Center of Excellence designation from DNV.

Key Points: 
  • West Covina, California, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Emanate Health has become the first hospital in California to earn the Orthopedic Center of Excellence designation from DNV.
  • “It is a privilege to recognize Emanate Health as the first Orthopedic Center of Excellence in California,” said Kelly Proctor, President of DNV Healthcare USA Inc. “Earning this distinction required dedication from orthopedic leadership and staff; it’s not an easy undertaking.”
    Achieving Orthopedic Center of Excellence designation requires that a hospital obtain advanced certification with DNV in at least three (3) of their orthopedic service line programs.
  • “Emanate Health is honored to be the first in the State of California and on the West Coast to achieve designation as a DNV Orthopedic Center of Excellence,” said Roger Sharma, CPA, MBA, President & CEO of Emanate Health.
  • I want to recognize and thank the entire team for their hard work in getting us formally recognized as a DNV Center of Excellence,” said Thomas O. Bryan, MD, orthopedic surgeon at Emanate Health.

Orthopedic Center of Florida Announces Partnership with HOPCo

Retrieved on: 
Thursday, November 3, 2022

FORT MYERS, Fla., Nov. 3, 2022 /PRNewswire/ -- Orthopedic Center of Florida, recognized nationally and locally as leaders in orthopedics since 1986, has announced it has partnered with Healthcare Outcomes Performance Company (HOPCo), the national leader in musculoskeletal practice and clinical outcomes management solutions and the largest orthopedic value-based care organization in the country. This partnership will develop unique clinically integrated partnerships with musculoskeletal practices, physicians, health systems, and payors throughout southwest Florida and the surrounding regions. 

Key Points: 
  • As part of this new partnership with HOPCo, Orthopedic Center of Florida will expand its practice into Naples, Florida, with the addition of several new physicians whose specialties will include joint replacement, sports medicine and spine care.
  • "For over 35 years, our group has provided high-quality care to the Fort Myers community," said Dr. John Mehalik of Orthopedic Center of Florida.
  • "Orthopedic Center of Florida's reputation for patient-centered care, coupled with their aspiration for growth, made them an ideal partner for HOPCo," said Dr. Wael Barsoum, President and Chief Transformation Officer of HOPCo.
  • "Our goal is to leverage the tools and platforms we have developed over the last 15 years to help Orthopedic Center of Florida lead the transformation of musculoskeletal care across southwest Florida."

Orthopedic Care Partners Adds Physician Practice of St. Louis Surgeon, Dr. Nathan Mall

Retrieved on: 
Wednesday, October 19, 2022

Malls practice to Motion Orthopaedics aligns with our strategy of pursuing long-term partnerships with renowned, highly trained physicians.

Key Points: 
  • Malls practice to Motion Orthopaedics aligns with our strategy of pursuing long-term partnerships with renowned, highly trained physicians.
  • Mall spent over six years as an Orthopaedic Surgeon at the Orthopedic Center of St. Louis.
  • OCP is backed by Varsity Healthcare Partners (VHP), a lower middle-market healthcare services private equity investment firm with expertise in growing care provider platforms.
  • Orthopedic Care Partners (OCP) is the leading partner for high-performing, quality and patient-focused orthopedic surgery practices.

Two-Year Clinical Data for DiscGenics's Progenitor Cell Therapy for Lumbar Disc Degeneration to Be Presented at NASS 2022

Retrieved on: 
Tuesday, October 11, 2022

Dr. Gornet's presentation will take place on Wednesday, October 12 at 1:06PM Central Time during the Lumbar Degenerative Pathology Abstract Presentations in Room W471ab.

Key Points: 
  • Dr. Gornet's presentation will take place on Wednesday, October 12 at 1:06PM Central Time during the Lumbar Degenerative Pathology Abstract Presentations in Room W471ab.
  • DiscGenics is a sponsor of NASS 2022 and will host Booth# 5040 in the Exhibit Hall.
  • DiscGenics's first product candidate, IDCT (rebonuputemcel), is an allogeneic, injectable discogenic progenitor cell therapy for symptomatic, mild to moderate lumbar disc degeneration.
  • IDCT is a mixture of live Discogenic Cells, which are a unique progenitor cell population derived from donated adult human intervertebral disc tissue, and a viscous carrier.